QINLOCK

Medicinal product

(Invented) name

QINLOCK

Active substance (s)

Ripretinibas

Strength

50 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

L01EX19, ripretinib

Marketing authorisation holder

Deciphera Pharmaceuticals (Netherlands) B.V., Nyderlandai

Date of authorisation

2021-11-18

Date of renewal

Documents

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Ripretinibas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107592	93697	1093697	buteliukas	N30		Receptinis	EU/1/21/1569/001	Netiekiama	-	-	No	-	-
107593	93698	1093698	buteliukas	N90		Receptinis	EU/1/21/1569/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-11-18	Registruotas